First gener­ic com­pe­ti­tion ar­rives for Pfiz­er's megablock­buster an­ti-smok­ing drug

Since its FDA ap­proval in 2006 as a treat­ment to help peo­ple stop smok­ing, and even de­spite the risk of men­tal health is­sues added to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.